Immediate Impact

6 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 18

Citing Papers

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
7 intermediate papers

Works of Stefan Knackmuss being referenced

Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors
2021
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+tumor cells
2014
and 3 more

Author Peers

Author Last Decade Papers Cites
Stefan Knackmuss 629 652 476 523 41 1.4k
Ezogelin Oflazoglu 724 802 698 462 23 1.7k
Carolyn S. Ernst 748 434 445 879 33 1.7k
Sandra Verploegen 707 687 503 637 26 1.6k
Ivan J. Stone 910 991 303 559 33 1.5k
Xianming Huang 272 388 523 942 41 1.7k
N K Cheung 335 414 527 564 31 1.6k
Seung Y. Chu 804 439 684 503 40 1.3k
D. M. Albert 378 322 260 504 47 1.7k
Alessandra Villa 589 569 426 619 37 1.3k
Z Steplewski 652 442 498 678 30 1.3k

All Works

Loading papers...

Rankless by CCL
2026